The END Fund is a private philanthropic initiative dedicated to controlling and eliminating neglected tropical diseases (NTDs). Founded in 2012, the organization focuses on delivering treatments for diseases such as intestinal worms, schistosomiasis, lymphatic filariasis, river blindness, and trachoma. By partnering with governments, NGOs, and private sector organizations, the END Fund aims to provide access to treatment for millions of people in need, particularly in Africa.
With a mission to ensure that all people at risk of NTDs have access to the necessary treatments, the END Fund mobilizes resources and expertise to support national programs. The organization emphasizes cost-effective interventions and sustainable solutions to combat these diseases, which affect the world’s most impoverished communities.
Profile & Classification
Entity Type: Private Company
Founding Year: 2012
Scale/Resources: Large-scale operations
Main Sectors: Health, Philanthropy
Countries of Intervention
The END Fund primarily focuses on African countries, including Ethiopia, Kenya, Nigeria, Rwanda, and Zimbabwe, among others.
Key Programs & Opportunities
The END Fund’s key programs involve mass drug administration campaigns, health education, and disease mapping. The organization actively seeks professionals passionate about global health and offers various career opportunities in program management, fundraising, and communications.
Key Performances & Impact
Since its inception, the END Fund has successfully delivered over 700 million treatments to those in need. The organization has played a pivotal role in reducing the prevalence of NTDs in several countries, improving the quality of life and economic prospects for millions of individuals.